Aktie A2ABSD ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Zhongzhi Pharmaceutical Holdings Limited

Aktien

A2ABSD

KYG989611085

3737

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:20 26.04.2024 		% 5 Tage % 1. Jan.
1.22 HKD 0.00% Intraday Chart für Zhongzhi Pharmaceutical Holdings Limited +1.67% -14.08%
25.03. Zhongzhi Pharmaceutical's zurechenbarer Gewinn steigt im Jahr 2023 MT
22.03. Zhongzhi Pharmaceutical Holdings Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Zhongzhi Pharmaceutical's Attributable Jumps in 2023
Zhongzhi Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 13 June 2024
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Zhongzhi Pharmaceutical Expects Over 50% Surge in 2023 Profit
Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
Zhongzhi Pharmaceutical Holdings Limited Approves Interim Dividend
Zhongzhi Pharmaceutical’s Profit Up 75% in H1
Zhongzhi Pharmaceutical Holdings Limited Proposes Interim Dividend for the Six Months Ended 30 June 2023, Payable on 2 November 2023
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Zhongzhi Pharmaceutical Expects 70% Increase in H1 Profit; Shares Jump 7%
Zhongzhi Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended June 30, 2023
Zhongzhi Pharmaceutical Unit Chooses Builder for New Factory
Zhongshan Hengsheng Enters into the Construction Contract with Shenzhen Xinmei
Zhongzhi Pharmaceutical Holdings Limited Approves the Declaration and Payment of Special Dividend
Zhongzhi Pharmaceutical Holdings Limited Approves the Declaration and Payment of Final Dividend
Zhongzhi Pharmaceutical Holdings Limited Proposes Special Dividend for the Year Ended 31 December 2022, Payable on 16 June 2023
Zhongzhi Pharmaceutical Holdings Limited Proposes Payment of Final Dividend for the Year Ended 31 December 2022, Payable on 16 June 2023
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Zhongzhi Pharmaceutical Sees Twofold Jump in FY22 Profit
Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2ABSD Aktie
  4. Nachrichten Zhongzhi Pharmaceutical Holdings Limited
  5. Andere Sprachen